These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 34831021)

  • 41. [Hepatitis B and C: mechanisms of virus-induced liver pathogenesis and tumorigenesis].
    Glitscher M; Hildt E; Bender D
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 Feb; 65(2):228-237. PubMed ID: 35015106
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatitis E virus: An ancient hidden enemy in Latin America.
    Fierro NA; Realpe M; Meraz-Medina T; Roman S; Panduro A
    World J Gastroenterol; 2016 Feb; 22(7):2271-83. PubMed ID: 26900289
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Robust hepatitis E virus infection and transcriptional response in human hepatocytes.
    Todt D; Friesland M; Moeller N; Praditya D; Kinast V; Brüggemann Y; Knegendorf L; Burkard T; Steinmann J; Burm R; Verhoye L; Wahid A; Meister TL; Engelmann M; Pfankuche VM; Puff C; Vondran FWR; Baumgärtner W; Meuleman P; Behrendt P; Steinmann E
    Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1731-1741. PubMed ID: 31896581
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis E virus superinfection impairs long-term outcome in hospitalized patients with hepatitis B virus-related decompensated liver cirrhosis.
    Zhao H; Ye W; Yu X; Hu J; Zhang X; Yang M; Sheng J; Shi Y
    Ann Hepatol; 2023; 28(2):100878. PubMed ID: 36417965
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Viral ORF3 Protein Is Required for Hepatitis E Virus Apical Release and Efficient Growth in Polarized Hepatocytes and Humanized Mice.
    Sari G; Zhu J; Ambardekar C; Yin X; Boonstra A; Feng Z; Vanwolleghem T
    J Virol; 2021 Nov; 95(23):e0058521. PubMed ID: 34523963
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Review article: hepatitis E-a concise review of virology, epidemiology, clinical presentation and therapy.
    Donnelly MC; Scobie L; Crossan CL; Dalton H; Hayes PC; Simpson KJ
    Aliment Pharmacol Ther; 2017 Jul; 46(2):126-141. PubMed ID: 28449246
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current situation of viral hepatitis in Egypt.
    Elbahrawy A; Ibrahim MK; Eliwa A; Alboraie M; Madian A; Aly HH
    Microbiol Immunol; 2021 Sep; 65(9):352-372. PubMed ID: 33990999
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pathogenesis and treatment of hepatitis e virus infection.
    Wedemeyer H; Pischke S; Manns MP
    Gastroenterology; 2012 May; 142(6):1388-1397.e1. PubMed ID: 22537448
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Why all blood donations should be tested for hepatitis E virus (HEV).
    Denner J; Pischke S; Steinmann E; Blümel J; Glebe D
    BMC Infect Dis; 2019 Jun; 19(1):541. PubMed ID: 31221098
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Advances in Hepatitis E Virus Biology and Pathogenesis.
    Lin S; Zhang YJ
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33572257
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatitis E, what is the real issue?
    Larrue H; Abravanel F; Peron JM
    Liver Int; 2021 Jun; 41 Suppl 1():68-72. PubMed ID: 33975382
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A small animal model of chronic hepatitis E infection using immunocompromised rats.
    Sridhar S; Wu S; Situ J; Shun EH; Li Z; Zhang AJ; Hui K; Fong CH; Poon VK; Chew NF; Yip CC; Chan WM; Cai JP; Yuen KY
    JHEP Rep; 2022 Oct; 4(10):100546. PubMed ID: 36052220
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sofosbuvir in the Treatment of Hepatitis E virus Infection: A Review of
    Lampejo T
    J Clin Exp Hepatol; 2022; 12(4):1225-1237. PubMed ID: 35814503
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatitis E seroprevalence and viremia rate in immunocompromised patients: a systematic review and meta-analysis.
    Buescher G; Ozga AK; Lorenz E; Pischke S; May J; Addo MM; Horvatits T
    Liver Int; 2021 Mar; 41(3):449-455. PubMed ID: 33034121
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Monitoring of hepatitis E virus RNA during treatment for chronic hepatitis E virus infection after renal transplantation.
    Affeldt P; Di Cristanziano V; Grundmann F; Wirtz M; Kaiser R; Benzing T; Stippel D; Kann M; Kurschat C
    Immun Inflamm Dis; 2021 Jun; 9(2):513-520. PubMed ID: 33559399
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The impact of hepatitis E in the liver transplant setting.
    Behrendt P; Steinmann E; Manns MP; Wedemeyer H
    J Hepatol; 2014 Dec; 61(6):1418-29. PubMed ID: 25195557
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is hepatitis E virus an emerging problem in industrialized countries?
    Sayed IM; Vercouter AS; Abdelwahab SF; Vercauteren K; Meuleman P
    Hepatology; 2015 Dec; 62(6):1883-92. PubMed ID: 26175182
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatitis E Virus Mutations: Functional and Clinical Relevance.
    van Tong H; Hoan NX; Wang B; Wedemeyer H; Bock CT; Velavan TP
    EBioMedicine; 2016 Sep; 11():31-42. PubMed ID: 27528267
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serological and genetic diversity of hepatitis E virus among rabbits population in Egypt.
    El-Adly AM
    Open Vet J; 2023 May; 13(5):515-522. PubMed ID: 37304608
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modulation of SOCS3 Levels via STAT3 and Estrogen-ERαp66 Signaling during Hepatitis E Virus Replication in Hepatocellular Carcinoma Cells.
    Sooryanarain H; Heffron CL; Mahsoub HM; Hassebroek AM; Wang B; Tian D; Ahmed SA; Meng XJ
    J Virol; 2022 Oct; 96(19):e0100822. PubMed ID: 36102649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.